7. Total Bilirubin ≤ 1.5 x Upper Limit of Normal (ULN) and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < 2.5 x ULN (results within 7 days before study drug administration), ≤5×ULN for patients with liver metastases.